Congress continues a quiet recess. Lawmakers will be back on September 2, 2025. CMS releases final FY 2026 payment regulations. The Centers for Medicare & Medicaid Services (CMS) updated payment rates in the final fiscal year...more
8/25/2025
/ Centers for Medicare & Medicaid Services (CMS) ,
Children's Health Insurance Program (CHIP) ,
Department of Education ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
Executive Orders ,
Final Rules ,
Food and Drug Administration (FDA) ,
Immigration Procedures ,
Medicaid ,
Medicare ,
National Institute of Health (NIH) ,
One Big Beautiful Bill Act ,
Proposed Rules ,
Public Service Loan Forgiveness program (PSLF program) ,
SCOTUS
House Energy & Commerce Health Subcommittee Holds Legislative Hearing on Improving Medicaid Access. Daniel Tsai, deputy administrator and director of the Center for Medicaid and CHIP Services (CMCS), testified. Members...more
5/6/2024
/ Centers for Medicare & Medicaid Services (CMS) ,
Children's Health Insurance Program (CHIP) ,
DACA ,
Department of Health and Human Services (HHS) ,
Department of Labor (DOL) ,
Final Rules ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Healthcare Reform ,
Legislative Agendas ,
Medicaid ,
Medicare ,
New Legislation ,
New Regulations ,
Regulatory Agenda ,
Senate Committees ,
U.S. House
Congress Returns Next Week to Face Imminent Funding Deadlines. The Senate will return to session on January 8, and the House will return on January 9. Lawmakers face an immediate time crunch on FY 2024 appropriations, as the...more
1/8/2024
/ Centers for Medicare & Medicaid Services (CMS) ,
Children's Health Insurance Program (CHIP) ,
Congressional Committees ,
Cybersecurity ,
Department of Health and Human Services (HHS) ,
Enrollment ,
GAO ,
Health Care Providers ,
Health Insurance ,
Healthcare ,
Healthcare Reform ,
Medical Devices ,
Medicare ,
OMB ,
Physician Fee Schedule
NEXT UP: SPEAKER MIKE JOHNSON -
The House officially has a speaker: Mike Johnson (R-LA).
On October 25, Rep. Johnson became Speaker Johnson with a final vote on the first ballot of 220–209.
Speaker Johnson, a...more
Congress was in session for a final week of legislative business before the two-week Independence Day recess. The House brought a small-business-focused healthcare bill to the floor, approving it along party lines....more
6/23/2023
/ Centers for Medicare & Medicaid Services (CMS) ,
Children's Health Insurance Program (CHIP) ,
Comment Period ,
Congressional Committees ,
Coronavirus/COVID-19 ,
Department of Health and Human Services (HHS) ,
Health Information Technologies ,
Healthcare ,
Legislative Agendas ,
Legislative Committees ,
Medicare ,
Medicare Access and CHIP Reauthorization (MACRA) ,
New Legislation ,
Proposed Legislation
The proposed rule would make transparency-related updates to state directed payments (SDPs). It would also require states to submit an annual payment analysis that compares managed care plans’ payment rates for routine...more
The House held a district work week while the Senate was in session, with plenty of healthcare action at the committee level. The Senate Finance Committee held a hearing on barriers to mental health care. The Senate Health,...more
5/8/2023
/ Biden Administration ,
Children's Health Insurance Program (CHIP) ,
Coronavirus/COVID-19 ,
DEA ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
HELP ,
MACPAC ,
Mental Health ,
Pharmaceutical Industry ,
Public Health Emergency
Congress was in session, and it was a busy healthcare week at the committee level, with six hearings focused specifically on health issues. On the House floor, Republicans passed the Limit, Save, Grow Act—a bill that raises...more
5/2/2023
/ Abortion ,
Centers for Medicare & Medicaid Services (CMS) ,
Children's Health Insurance Program (CHIP) ,
Congressional Investigations & Hearings ,
Coronavirus/COVID-19 ,
DACA ,
Department of Health and Human Services (HHS) ,
Enforcement Actions ,
Federal Funding ,
Health Insurance ,
Healthcare ,
Healthcare Reform ,
HELP ,
Hospitals ,
Medicaid ,
New Legislation ,
Pharmaceutical Industry ,
Prescription Drugs ,
Price Transparency ,
Proposed Legislation ,
Proposed Rules ,
Right of Access